Search

Your search keyword '"Goldsmith CE"' showing total 81 results

Search Constraints

Start Over You searched for: Author "Goldsmith CE" Remove constraint Author: "Goldsmith CE" Search Limiters Full Text Remove constraint Search Limiters: Full Text
81 results on '"Goldsmith CE"'

Search Results

1. Molecular epidemiology of clinical isolates of Pseudomonas aeruginosa isolated from horses in Ireland

3. Meningococcal Disease in Northern Ireland - Past, Present & Future

5. Who's at The Door? - Surface Contamination of Door Frames in a Single-Bedded In-Patient Adult Cystic Fibrosis (CF) Unit.

6. Meningococcal Disease Section 3: Diagnosis and Management: MeningoNI Forum.

11. High diversity of bacterial pathogens and antibiotic resistance in salmonid fish farm pond water as determined by molecular identification employing 16S rDNA PCR, gene sequencing and total antibiotic susceptibility techniques.

12. Lactic acid bacterial infection, probiotics and gut microbiomes.

14. Population structure and characterization of viridans group streptococci (VGS) isolated from the upper respiratory tract of patients in the community.

15. Increased susceptibility to antibiotics in gram-negative and gram-positive pathogens, including Pseudomonas aeruginosa, at lower temperature: is antibiotic resistance reversal possible?

16. Antibiotic resistance reversal (ARR) in Gram-negative and Gram-positive pathogens employing electric fields.

17. Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients.

18. Bacterial stress response to environmental radiation relating to the Fukushima radiation discharge event, Japan: will environmental bacteria alter their antibiotic susceptibility profile?

19. Exposure to sublethal clinical radiotherapeutic doses of ionizing γ-radiation gives rise to mutants of Gram-negative and Gram-positive clinical pathogens with increased antibiotic resistance.

20. Molecular characterisation of the quinolone resistance-determining regions (QRDR) including gyrA, gyrB, parC and parE genes in Streptococcus pneumoniae.

21. Isolation and identification of 'Mycobacterium angelicum' from a patient with type II respiratory failure: suggested reporting guidelines to molecular clinical laboratories.

22. Exposure to clinical X-ray radiation does not alter antibiotic susceptibility or genotype profile in gram-negative and gram-positive clinical pathogens.

23. Polymerase chain reaction amplification: effect of dyes and other staining agents employed in clinical microbiology laboratories.

24. Examination of the antibacterial properties of sphagnum moss (Sphagnum spp.) and its significance with turf burning in Ireland.

25. Antibacterial effects on acinetobacter species of commonly employed antineoplastic agents used in the treatment of haematological malignancies: an in vitro laboratory evaluation.

26. Maintaining culturability of Streptococcus pneumoniae (pneumococci) during transportation.

27. Mining the antibiogram: what more can it tell us?

28. Comparison of minimum inhibitory concentration by broth microdilution testing versus standard disc diffusion testing in the detection of penicillin, erythromycin and ciprofloxacin resistance in viridans group streptococci.

29. Identification and characterization of breakthrough contaminants associated with the conventional isolation of Mycobacterium tuberculosis.

30. Clinical experience with generic levetiracetam in people with epilepsy.

31. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).

32. Comparasion of five gene loci (rnpB, 16S rRNA, 16S-23S rRNA, sodA and dnaJ) to aid the molecular identification of viridans-group streptococci and pneumococci.

33. Comparison of the identification of Acinetobacter spp. with API20NE and 16S rRNA gene sequencing techniques.

34. Prevalence of clustered regulatory interspaced short palindromic repeat (CRISPR)-like sequences in mitis-group streptococci.

35. Molecular characterisation of the quinolone resistance-determining region (QRDR) of the parC gene locus in viridans-group streptococci.

37. Screening of clinical, food, water and animal isolates of Escherichia coli for the presence of blaCTX-M extended spectrum beta-lactamase (ESBL) antibiotic resistance gene loci.

38. Direct comparison of in vitro susceptibility of wildtype clinical Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) to TOBI and BRAMITOB (tobramycin inhalation solutions).

39. Molecular identification of airborne bacteria associated with aerial spraying of bovine slurry waste employing 16S rRNA gene PCR and gene sequencing techniques.

40. Molecular conservation within LES9F and PS21 liverpool epidemic strain (LES) markers in wild-type clinical pseudomonas aeruginosa isolated from the sputum of adult patients with cystic fibrosis.

41. Optimisation of storage conditions for maintaining culturability of penicillin-susceptible and penicillin-resistant isolates of Streptococcus pneumoniae in transport medium.

42. Do equine strains of Pseudomonas aeruginosa carry the Liverpool epidemic strain markers relevant to patients with cystic fibrosis?

43. Non-coding small (micro) RNAs of Pseudomonas aeruginosa isolated from clinical isolates from adult patients with cystic fibrosis.

44. Comparison of public perceptions associated with healthcare-associated infections (HCAIS) in Northern Ireland following the 2007/2008 outbreak of Clostridium difficile in the Northern Trust.

46. Determination of optimum incubation time for release of bacteria from sputum of patients with cystic fibrosis using dithiothreitol (sputasol).

47. Molecular characterisation of the recA locus in clinical isolates of verocytotoxigenic E. coli O157:H7.

48. An examination of antibacterial and antifungal properties of constituents described in traditional Ulster cures and remedies.

49. Long-term antibiotic treatment of patients with cystic fibrosis: a commensal organism's view.

Catalog

Books, media, physical & digital resources